Derisking Early Research and Increasing Likelihood of Clinical Success

Is there a secret recipe for successful partnerships between founders and their investment partners that can maximize value of their assets and improve the odds for clinical success? Join this panel of leading translational and development experts from the start-up ecosystem that looks beyond capital investment for start-ups. These collaborative models work to deliver significant added value to early and translational research efforts through active, operational partnerships focused on driving a program forward. Learn how they engage with portfolio companies to grow their knowledge base, develop realistic clinical programs, manage expectations and enable development of commercially viable pharma and biotech assets.